BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Clinical Rockstar Pamela Tenaerts Advancing Patient-Centric Trials at Medable

  As Tenaerts takes the scientific helm at Medable, she will leverage the company’s proprietary platform to advance decentralized research methodologies with evidence-based best practices for patient-centric clinical trials.

  May 2, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Business

  Q1 2021: A Look at Top 25 Biopharma Companies by Market Cap

  BioSpace takes an in-depth look at the Top 25 of Q1. You should be aware of these biopharma companies as they hold a great future ahead. So, check them out.

  May 2, 2021

   · 

  14 min read

   · 

  Heather McKenzie
• Policy

  CPHO Sunday Edition - May 2, 2021 - Highlighting Canada’s Research Contributions: Polio and COVID-19 Vaccines

  This past week was National Immunization Awareness Week, an annual event that serves to highlight the importance of immunization, and which I discussed in some detail in last week’s Sunday Edition.

  May 2, 2021

   · 

  8 min read
• Policy

  Jacobio Announces FDA Approves IND Application to Develop KRAS G12C Inhibitor

  The clinical trials of KRAS G12C inhibitors are expected to enroll patients in the second half of 2021. Jacobio is aiming for the in-house combination therapy of KRAS G12C and SHP2 inhibitors.

  May 2, 2021

   · 

  5 min read